Search results
This CHEST guideline series presents recommendations for the diagnosis, treatment, and management of patients with lung cancer, covering the full spectrum of care from initial evaluation to palliative and end-of-life care. Additional recommendations include screening, chemoprevention, and treatment of tobacco use in patients with lung cancer.
The ACC/AHA Joint Committee on Clinical Practice Guidelines has commissioned this guideline to focus on the evaluation of acute or stable chest pain or other anginal equivalents, in various clinical settings, with an emphasis on the diagnosis on ischemic causes.
28 paź 2021 · The “2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain” provides recommendations based on contemporary evidence on the assessment and evaluation of chest pain.
Summary of Recommendations. In patients with chronic obstructive pulmonary disease (COPD) who complain of dyspnea or exercise intolerance, we recommend long-acting b2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) combination therapy over LABA or LAMA monotherapy (strong recommendation, moderate certainty evidence).
ESMO has Clinical Practice Guidelines on the following Lung and Chest Tumours: Early and locally advanced non-small-cell lung cancer, Metastatic non-small-cell lung cancer, Thymic epithelial tumours, Malignant pleural mesothelioma, Small-cell lung cancer.
In the following, recommendations for the treatment of stable chronic obstructive pulmonary disease (COPD) will be presented. It should be emphasized, however, that some ideal characteristics will also be mentioned for those with a recent COPD exacerbation.
2 lis 2021 · The AHA/ACC Chest Pain Guideline is a “clinical practice guideline for the evaluation and diagnosis of chest pain that provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.”
